Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Autologous Stem Cell Transplantation in Waldenstrom's Macroglobulinemia

Krina Patel, MD, Rima M Saliba, PhD, Nina Shah, MD, Qaiser Bashir, Sheeba K. Thomas, MD, Yvonne T Dinh, Chitra M. Hosing, M.D., Uday R. Popat, M.D., Simrit Parmar, M.D., Sergio A Giralt, MD, Richard E. Champlin, Muzaffar H. Qazilbash, MD

Blood (2012) 120 (21): 4533.

https://doi.org/10.1182/blood.V120.21.4533.4533

Published: 2012

Journal Articles

EBMT Risk Score for Pre Transplant Risk Assessment in Patients with Multiple Myeloma.

Zartash Gul, MD, Hasan Khan, Qaiser Bashir, MD, Nina Shah, MD, Simrit Parmar, M.D., Yvonne T Dinh, Chitra M. Hosing, M.D., Uday R. Popat, M.D., Partow Kebriaei, M.D., Paolo Anderlini, MD, Elizabeth J Shpall, MD, Sergio Giralt, MD, Richard E. Champlin, Muzaffar H. Qazilbash, MD

Blood (2012) 120 (21): 3094.

https://doi.org/10.1182/blood.V120.21.3094.3094

Published: 2012

Journal Articles

Cardiac Toxicity After High-Dose Melphlan and Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Zartash Gul, MD, Qaiser Bashir, MD, Yago Nieto, M.D., Ph.D., Nazeer Sherwani, Simrit Parmar, M.D., Nina Shah, MD, Yvonne T Dinh, Chitra M. Hosing, M.D., Uday R. Popat, M.D., Partow Kebriaei, M.D., Elizabeth J Shpall, MD, Sergio A Giralt, MD, Richard E. Champlin, Muzaffar H. Qazilbash, MD

Blood (2012) 120 (21): 2027.

https://doi.org/10.1182/blood.V120.21.2027.2027

Published: 2012

Journal Articles

Leukemia Cell Mobilization with Plerixafor Plus G-CSF with Busulfan/Fludarabine and Allogeneic Hematopoietic Cell Transplantation in Patients with AML/MDS Is Associated with Decreased Complete Chimerism and GvHD, and Increased Risk of Relapse

Blood (2012) 120 (21): 360.

https://doi.org/10.1182/blood.V120.21.360.360

Published: 2012

Journal Articles

Induction of PD-1 and PD-1 Ligand Expression by Hypomethylating Agents (HMA) in Myelodysplastic Syndromes and Acute Myelogenous Leukemia Suggest a Role for T Cell Function in Clinical Resistance to Hmas

Hui Yang, MD, PhD., Carlos E. Bueso-Ramos, MD, PhD, Simrit Parmar, M.D., Yue Wei, PhD, Zhihong Fang, Martin Nguyen, Michael Fernandez, Sherry A. Pierce, RN, BS, Qirong Geng, Hagop M. Kantarjian, MD, Jorge E Cortes, MD, Guillermo Garcia-Manero, MD

Blood (2012) 120 (21): 3810.

https://doi.org/10.1182/blood.V120.21.3810.3810

Published: 2012

Journal Articles

Phase 1/1b Study of the Efficacy and Safety of the Combination of Panobinostat + Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma

Jatin J. Shah, M.D., Sheeba K. Thomas, MD, Donna M. Weber, M.D., Michael Wang, M.D., Raymond Alexanian, M.D., Muzaffar H. Qazilbash, MD, Qaiser Bashir, MD, Simrit Parmar, M.D., Nina Shah, MD, Uday R. Popat, M.D., Robert Z. Orlowski, M.D., Ph.D.

Blood (2012) 120 (21): 4081.

https://doi.org/10.1182/blood.V120.21.4081.4081

Published: 2012

Journal Articles

Phase 1 Study of the Novel Kinesin Spindle Protein Inhibitor ARRY-520 + Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma

Jatin J. Shah, M.D., Donna M. Weber, M.D., Sheeba K. Thomas, MD, Raymond Alexanian, M.D., Michael Wang, M.D., Muzaffar H. Qazilbash, MD, Simrit Parmar, M.D., Nina Shah, MD, Qaiser Bashir, MD, Uday R. Popat, M.D., Brandi Hilder, Robert Z. Orlowski, M.D., Ph.D.

Blood (2012) 120 (21): 4082.

https://doi.org/10.1182/blood.V120.21.4082.4082

Published: 2012

Journal Articles

Role of Serum Lactate Dehydrogenase (LDH) As a Prognostic Marker for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

Krina Patel, MD, Robert Z. Orlowski, M.D., Ph.D., Nina Shah, MD, Qaiser Bashir, Simrit Parmar, M.D., Yvonne T Dinh, Gabriela Rondon, MD, Sergio A Giralt, MD, Richard E. Champlin, Muzaffar Qazilbash, M.D.

Blood (2012) 120 (21): 3115.

https://doi.org/10.1182/blood.V120.21.3115.3115

Published: 2012

Journal Articles

Final Results of a Phase I/II Trial of the Combination of Concurrent Lenalidomide, Thalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Myeloma

Jatin J. Shah, M.D., Robert Z. Orlowski, M.D., Ph.D., Sheeba K. Thomas, MD, Raymond Alexanian, M.D., Michael Wang, M.D., Muzaffar H. Qazilbash, MD, Uday R. Popat, M.D., Simrit Parmar, M.D., Nina Shah, MD, Qaiser Bashir, Richard E. Champlin, Donna M. Weber, M.D.

Blood (2012) 120 (21): 75.

https://doi.org/10.1182/blood.V120.21.75.75

Published: 2012

Journal Articles

High Dose Therapy Improves Survival in Systemic Light Chain Amyloidosis: 14 Year Follow up

Simrit Parmar, M.D., Joshua Howell, PharmD, Michael Wang, M.D., Mubeen A Khan, Qaiser Bashir, MD, Jatin J. Shah, M.D., Nina Shah, MD, Uday R. Popat, M.D., Sergio A Giralt, MD, Robert Z. Orlowski, M.D., Ph.D., Muzaffar Qazilbash, M.D.

Blood (2012) 120 (21): 750.

https://doi.org/10.1182/blood.V120.21.750.750

Published: 2012

Journal Articles

Low Dose Azacitidine Maintenance Therapy Following Allogeneic Stem Cell Transplantation for MDS/AML Does Not Interact with Tacrolimus Dosing or Serum Levels

Hans C. Lee, MD, Joshua Howell, PharmD, Denái Milton, MS, Sergio A Giralt, MD, Julianne J Chen, Gabriela Rondon, MD, Richard E. Champlin, Simrit Parmar, M.D., Marcos De Lima, MD

Blood (2012) 120 (21): 4209.

https://doi.org/10.1182/blood.V120.21.4209.4209

Published: 2012

Journal Articles

Feasibility of Hematopoietic Stem Cell Collection and Cryopreservation in Waldenstrom's Macroglobulinemia

Dilshad Khan, MBBS, Krina Patel, MD, Sheeba K. Thomas, MD, Donna M. Weber, M.D., Kay B Delasalle, B.S., Chitra M. Hosing, M.D., Uday R. Popat, M.D., Qaiser Bashir, MD, Nina Shah, MD, Simrit Parmar, M.D., Richard E. Champlin, Muzaffar Qazilbash, M.D.

Blood (2012) 120 (21): 4128.

https://doi.org/10.1182/blood.V120.21.4128.4128

Published: 2012

Journal Articles

Low Dose Azacitidine (AZA) Reduces the Incidence of Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Marcos de Lima, MD, Simrit Parmar, M.D., Julianne J Chen, Sergio A Giralt, MD, Gabriela Rondon, MD, Uday R. Popat, M.D., Amin M. Alousi, M.D., Hans C. Lee, MD, Glenda G Woodworth, RN, Chitra M Hosing, MD, Elizabeth J. Shpall, Partow Kebriaei, M.D., Guillermo garcia Manero, MD, Richard E. Champlin, Rima M. Saliba, Ph.D.

Blood (2012) 120 (21): 742.

https://doi.org/10.1182/blood.V120.21.742.742

Published: 2012

Journal Articles

Military Service in Vietnam/Korea and Serum Dioxin Levels Do Not Affect the Outcomes of Patients Diagnosed with Plasma Cell Dyscrasias

Prasanth Ganesan, MD, Emil Kuriakose, MD, Carla Smith, Robert T Harris, Jonathan E Dowell, MD, Arnold Schecter, Simrit Parmar, M.D.

Blood (2011) 118 (21): 5098.

https://doi.org/10.1182/blood.V118.21.5098.5098

Published: 2011

Journal Articles

A Comparative Study of the Outcome of High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Standard-Risk Myeloma Treated Concurrently,

Syed Kazmi, MD, Gary Lu, MD, Nina Shah, MD, Qaiser Bashir, MD, Simrit Parmar, M.D., Robert Z. Orlowski, MD, PhD, Jatin J Shah, MD, Chitra M Hosing, MD, Uday Popat, M.D., Yvonne T Dinh, Sofia Qureshi, Gabriela Rondon, MD, Sergio Giralt, MD, Richard Champlin, MD, Muzaffar H. Qazilbash, MD

Blood (2011) 118 (21): 4156.

https://doi.org/10.1182/blood.V118.21.4156.4156

Published: 2011

Journal Articles

CD137L Reverse the Immunological Synapse Defects of Natural Killer Cells in Acute Myeloid Leukemia

Dongxia Xing, Ph. D., Alan G. Ramsay, PhD, William Decker, PhD, Dean A. Lee, MD, PhD, Simon Robinson, PhD, Nina Shah, MD, Simrit Parmar, M.D., Catherine M. Bollard, MD, FRACP, FRCPA, Chitra M Hosing, MD, Richard Champlin, MD, John G. Gribben, MD, DSc, Elizabeth J Shpall, MD

Blood (2011) 118 (21): 246.

https://doi.org/10.1182/blood.V118.21.246.246

Published: 2011

Journal Articles

Impact of Non High-Risk Chromosomal Abnormalities on the Outcome of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Sairah Ahmed, MD, Heather Lin, PhD, Veera Baladandayuthapani, PhD, Mubeen A Khan, Gary Lu, MD, Gabriela Rondon, MD, Sofia Qureshi, Yvonne T Dinh, Qaiser Bashir, MD, Nina Shah, MD, Simrit Parmar, M.D., Chitra M Hosing, MD, Uday Popat, M.D., Sergio A Giralt, MD, Robert Z. Orlowski, MD, PhD, Jatin J Shah, MD, Richard Champlin, MD, Muzaffar H. Qazilbash, MD

Blood (2011) 118 (21): 333.

https://doi.org/10.1182/blood.V118.21.333.333

Published: 2011

Journal Articles

Phase I/II Trial of Fludarabine in Combination with Intravenous Busulfan and Allogeneic Progenitor Cell Support for Patients with High Risk Hematologic Malignancies; Dose Matters in Reduced Intensity Regimens

Simrit Parmar, M.D., Gabriela Rondon, MD, Peter F Thall, PhD, Roland Bassett, Marcos De Lima, MD, Chitra M Hosing, MD, Paolo Anderlini, MD, Partow Kebriaei, MD, Issa Khouri, MD, Prasanth Ganesan, MD, Yvonne A Efebera, M.D., Richard Champlin, MD, Sergio A Giralt, MD

Blood (2011) 118 (21): 1944.

https://doi.org/10.1182/blood.V118.21.1944.1944

Published: 2011

Journal Articles

Chromosome 7 Abnormalities in Allogeneic Transplantation for AML and MDS

Vamsi Kota, MBBS, Rima M. Saliba, PhD, Ulas D. Bayraktar, MD, Amer Beitinjaneh, MD, Julianne J Chen, Simrit Parmar, M.D., Sergio A Giralt, MD, Gabriela Rondon, MD, Stefan O Ciurea, MD, Partow Kebriaei, MD, Muzaffar H Qazilbash, MD, Borje S Andersson, MD, PhD, Richard Champlin, MD, Marcos De Lima, MD

Blood (2011) 118 (21): 2037.

https://doi.org/10.1182/blood.V118.21.2037.2037

Published: 2011

Journal Articles

Improved Early Outcomes with T-Cell Replete (TCR) Compared with T-Cell Depleted (TCD) Haploidentical Stem Cell Transplantation (HaploSCT)

Stefan O Ciurea, MD, Rima M. Saliba, PhD, Ulas D. Bayraktar, MD, Susan Xie, Gabriela Rondon, MD, Simrit Parmar, M.D., Partow Kebriaei, MD, Nivia Montes, PA, Manish Sharma, MD, Marina Konopleva, M.D., Ph.D., Yago Nieto, MD, PhD, Muzaffar H. Qazilbash, MD, Amin M Alousi, MD, Borje S Andersson, MD, PhD, Chitra M Hosing, MD, Elizabeth J Shpall, MD, Issa F. Khouri, MD, Marcos de Lima, MD, Richard Champlin, MD

Blood (2011) 118 (21): 320.

https://doi.org/10.1182/blood.V118.21.320.320

Published: 2011

NARROW

Autologous Stem Cell Transplantation in Waldenstrom's Macroglobulinemia

EBMT Risk Score for Pre Transplant Risk Assessment in Patients with Multiple Myeloma.

Cardiac Toxicity After High-Dose Melphlan and Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Leukemia Cell Mobilization with Plerixafor Plus G-CSF with Busulfan/Fludarabine and Allogeneic Hematopoietic Cell Transplantation in Patients with AML/MDS Is Associated with Decreased Complete Chimerism and GvHD, and Increased Risk of Relapse

Induction of PD-1 and PD-1 Ligand Expression by Hypomethylating Agents (HMA) in Myelodysplastic Syndromes and Acute Myelogenous Leukemia Suggest a Role for T Cell Function in Clinical Resistance to Hmas

Phase 1/1b Study of the Efficacy and Safety of the Combination of Panobinostat + Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma

Phase 1 Study of the Novel Kinesin Spindle Protein Inhibitor ARRY-520 + Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma

Role of Serum Lactate Dehydrogenase (LDH) As a Prognostic Marker for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

Final Results of a Phase I/II Trial of the Combination of Concurrent Lenalidomide, Thalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Myeloma

High Dose Therapy Improves Survival in Systemic Light Chain Amyloidosis: 14 Year Follow up

Low Dose Azacitidine Maintenance Therapy Following Allogeneic Stem Cell Transplantation for MDS/AML Does Not Interact with Tacrolimus Dosing or Serum Levels

Feasibility of Hematopoietic Stem Cell Collection and Cryopreservation in Waldenstrom's Macroglobulinemia

Low Dose Azacitidine (AZA) Reduces the Incidence of Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Military Service in Vietnam/Korea and Serum Dioxin Levels Do Not Affect the Outcomes of Patients Diagnosed with Plasma Cell Dyscrasias

A Comparative Study of the Outcome of High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Standard-Risk Myeloma Treated Concurrently,

CD137L Reverse the Immunological Synapse Defects of Natural Killer Cells in Acute Myeloid Leukemia

Impact of Non High-Risk Chromosomal Abnormalities on the Outcome of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Phase I/II Trial of Fludarabine in Combination with Intravenous Busulfan and Allogeneic Progenitor Cell Support for Patients with High Risk Hematologic Malignancies; Dose Matters in Reduced Intensity Regimens

Chromosome 7 Abnormalities in Allogeneic Transplantation for AML and MDS

Improved Early Outcomes with T-Cell Replete (TCR) Compared with T-Cell Depleted (TCD) Haploidentical Stem Cell Transplantation (HaploSCT)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only